Hbk Investments L P Neurocrine Biosciences Inc Transaction History

Hbk Investments L P

  • $3.93 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$68.32 - $124.36 $196,966 - $358,529
-2,883 Reduced 32.46%
6,000 $428,000
Q3 2018

Nov 14, 2018
SELL
$98.88 - $125.85 $751,389 - $956,334
-7,599 Reduced 46.1%
8,883 $1.09 Million
Q2 2018

Aug 14, 2018
BUY
$75.3 - $105.99 $1.24 Million - $1.75 Million
16,482 New
16,482 $1.62 Million

Others Institutions Holding NBIX

# of Institutions
656
Shares Held
95.3M
Call Options Held
282K
Put Options Held
281K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $9.08B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Hbk Investments L P Portfolio

Follow Hbk Investments L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

News

Stay updated on Hbk Investments L P with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email